Norihiko Saito

Norihiko Saito


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 February 2015 in Brain Tumor Pathology
Verified
Journal Article
Closed access
PDF file
NSNorihiko Saito
Norihiko Saito
KAKazuya Aoki
Kazuya Aoki
NHNozomi Hirai
Nozomi Hirai
SFSatoshi Fujita
Satoshi Fujita
JIJunya Iwama
Junya Iwama
SISatoshi Iwabuchi
Satoshi Iwabuchi

12 November 2007 in International Journal of Experimental Pathology
Verified
Journal Article
Closed access
PDF file
NSNorihiko Saito
Norihiko Saito
THTsutomu Hatori
Tsutomu Hatori
NMNozomu Murata
Nozomu Murata
ZZZe‐An Zhang
Ze‐An Zhang
HNHiroko Nonaka
Hiroko Nonaka
MUMorikazu Ueda
Morikazu Ueda

20 January 2019 in Cancers
Verified
Journal Article
Open access
PDF file
NSNorihiko Saito
Norihiko Saito
NHNozomi Hirai
Nozomi Hirai
KAKazuya Aoki
Kazuya Aoki
RSRyo Suzuki
Ryo Suzuki
SFSatoshi Fujita
Satoshi Fujita
SISatoshi Iwabuchi
Satoshi Iwabuchi
The NOTCH pathway regulates neural stem cells and glioma initiating cells (GICs). However, blocking NOTCH activity with γ-secretase inhibitors (GSIs) fails to alter the growth of GICs, as GSIs seem to be active in only a fraction of GICs lines with constitutive NOTCH activity. Here we report loss of PTEN function as a critical event leading to resistance to NOTCH inhibition, which causes the transfer of oncogene addiction from the NOTCH pathway to the PI3K pathway. Drug cytotoxicity testing of eight GICs showed a differential growth response to GSI, and the GICs were thus stratified into two groups: sensitive and resistant. In the sensitive group, GICs with loss of PTEN function appeared less sensitive to GSI treatment. Here we show that NOTCH regulates PTEN expression and the activity of the PI3K pathway in GICs, as treatment with GSI attenuated the NOTCH pathway and increased PTEN expression. NOTCH regulates PTEN expression via Hes-1, as knockdown of Notch or Hes1 increased expression of PTEN. This novel observation suggests that both pathways must be simultaneously inhibited in order to improve therapeutic efficacy in human glioblastomas (GBMs).

22 January 2007 in Neuropathology and Applied Neurobiology
Verified
Journal Article
Closed access
PDF file
NSNorihiko Saito
Norihiko Saito
THT. Hatori
T. Hatori
NMN. Murata
N. Murata
ZZZ.‐A. Zhang
Z.‐A. Zhang
FIF. Ishikawa
F. Ishikawa
HSH. Samejima
H. Samejima

1 January 2010 in Neurologia medico-chirurgica
Verified
Journal Article
Open access
NSNorihiko Saito
Norihiko Saito
KAKazuya Aoki
Kazuya Aoki
TSTakatoshi Sakurai
Takatoshi Sakurai
KIKeisuke Ito
Keisuke Ito
MHMorito Hayashi
Morito Hayashi
SISatoshi Iwabuchi
Satoshi Iwabuchi
Two patients were treated for intracranial infections involving methicillin-resistant Staphylococcus aureus (MRSA). A 30-year-old woman was admitted to our hospital for intracerebral hemorrhage related to arteriovenous malformation. After decompressive craniectomy, the patient developed an epidural abscess. MRSA was isolated from the pus culture. The infection did not improve after intravenous vancomycin (VCM) administration for 15 days. However, after administration of linezolid (LZD) for 14 days, the infection had improved, and the white blood cell count and C-reactive protein values had normalized. A 53-year-old woman had previously undergone 3 operations for craniopharyngioma before the age of 35 years. She was admitted to our hospital with fever and disturbance of consciousness. Magnetic resonance imaging with contrast medium revealed a brain abscess caused by MRSA. After 14 days of intravenous administration of VCM, the infection had not improved and intravenous administration of LZD was initiated. After administration of LZD for 14 days intravenously and 14 days orally, the infection had improved, and the white blood cell count and C-reactive protein values had normalized. VCM is highly effective against MRSA infection, but penetration into the central nervous system (CNS) is poor. LZD has good CNS penetration, so should be considered for secondline antibiotic therapy for VCM-resistant intracranial MRSA infection.

15 October 2019 in Cancers
Verified
Journal Article
Open access
PDF file
NSNorihiko Saito
Norihiko Saito
NHNozomi Hirai
Nozomi Hirai
KAKazuya Aoki
Kazuya Aoki
SSSho Sato
Sho Sato
RSRyo Suzuki
Ryo Suzuki
SISatoshi Iwabuchi
Satoshi Iwabuchi
The Cancer Genome Atlas (TCGA) project described a robust gene expression-based molecular classification of glioblastoma (GBM), but the functional and biological significance of the subclasses has not been determined. The present comprehensive analysis of 25 glioma-initiating cell (GIC) lines classifies GIC lines into four subtypes (classical, mesenchymal, proneural, and neural) that are closely related to the TCGA GBM subclasses and display distinct lineage characteristics and differentiation behavior that recapitulate neural development. More importantly, the GIC subtypes exhibit distinct biological phenotypes in relation to self-renewal capacity, proliferation, invasiveness, and angiogenic potential in vitro and in vivo. In addition, the GIC subtypes exhibit divergent patterns of signaling pathway activation and deactivation of the Wnt, Notch, and TGF-β pathways. These results will improve drug discovery targeting certain genetic mutation in glioblastoma and improve the development of precision medicine.